Revenue: The sum of all revenue fields included for a company's operating activities.
INmune Bio, Inc. (INMB) had Revenue of $0.05M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$0.05M |
$-9.74M |
|
-- |
|
$0.05M |
|
$9.96M |
|
$-9.90M |
|
$0.17M |
|
$-9.74M |
|
$-9.74M |
|
$-9.74M |
|
$-9.74M |
|
$-9.74M |
|
$-9.74M |
|
$-9.90M |
|
$-9.90M |
|
22.50M |
|
22.50M |
|
$-0.43 |
|
$-0.43 |
|
| Balance Sheet Financials | |
$20.96M |
|
-- |
|
$16.84M |
|
$37.80M |
|
$7.93M |
|
-- |
|
$0.20M |
|
$8.13M |
|
$29.67M |
|
$13.16M |
|
$29.67M |
|
22.30M |
|
| Cash Flow Statement Financials | |
$-6.82M |
|
-- |
|
$5.27M |
|
$20.92M |
|
$19.34M |
|
$-1.58M |
|
$2.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.64 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-19810.00% |
|
-19810.00% |
|
-- |
|
-19478.00% |
|
-19478.00% |
|
$-6.82M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.04 |
|
2548.80 |
|
-32.82% |
|
-74.01% |
|
-25.76% |
|
-32.82% |
|
$1.33 |
|
$-0.30 |
|
$-0.30 |
|